Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Clovis Oncology (CLVS) stocks in Canada
Learn how to easily invest in Clovis Oncology stocks.
Clovis Oncology (CLVS) is a leading biotechnology business based in the US. It opened the day at $5.41 after a previous close of $5.39. During the day the price has varied from a low of $5.235 to a high of $5.46. The latest price was $5.42 (25 minute delay). Clovis Oncology is listed on the NASDAQ and employs 429 staff. All prices are listed in US Dollars.
How to buy shares in Clovis Oncology
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CLVS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Clovis Oncology?
- Has coronavirus impacted Clovis Oncology shares?
- Clovis Oncology shares summary
- Compare share dealing platforms
- Is Clovis Oncology stock a buy or sell?
- Clovis Oncology performance over time
- Are Clovis Oncology shares over-valued?
- Clovis Oncology's financials
- How volatile are Clovis Oncology shares?
- Does Clovis Oncology pay a dividend?
- Other common questions
Clovis Oncology stock price (NASDAQ:CLVS)Use our graph to track the performance of CLVS stocks over time.
Clovis Oncology shares at a glance
|52-week range||$1.97 - $11.10|
|50-day moving average||$3.01|
|200-day moving average||$4.58|
|Wall St. target price||$6.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.78|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Clovis Oncology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Clovis Oncology price performance over time
|1 week (2022-01-21)||147.49%|
|1 month (2021-12-24)||N/A|
|3 months (2021-10-28)||23.74%|
|6 months (2021-07-28)||6.48%|
|1 year (2021-01-28)||-35.55%|
|2 years (2020-01-27)||-36.76%|
|3 years (2019-01-25)||24.48|
|5 years (2017-01-27)||62.5|
Is Clovis Oncology under- or over-valued?
Valuing Clovis Oncology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Clovis Oncology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Clovis Oncology's PEG ratio
Clovis Oncology's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.13. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Clovis Oncology's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Clovis Oncology financials
|Revenue TTM||$156.1 million|
|Gross profit TTM||$128.4 million|
|Return on assets TTM||-26.4%|
|Return on equity TTM||0%|
|Market capitalisation||$284.7 million|
TTM: trailing 12 months
Clovis Oncology share dividends
We're not expecting Clovis Oncology to pay a dividend over the next 12 months.
Clovis Oncology share price volatility
Over the last 12 months, Clovis Oncology's shares have ranged in value from as little as $1.9701 up to $11.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Clovis Oncology's is 1.5849. This would suggest that Clovis Oncology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Clovis Oncology overview
Clovis Oncology, Inc. , a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U. S. , the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the company offers Rubraca for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is also developing lucitanib, an investigational angiogenesis inhibitor, which inhibits vascular endothelial growth factor receptors 1 through 3 (VEGFR 1-3), platelet-derived growth factor receptors alpha and beta (PDGFRa/ß), and fibroblast growth factor receptors 1 through 3 (FGFR 1-3); and FAP-2286, an investigational peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein.
Stocks similar to Clovis Oncology
Clovis Oncology in the news
Insiders are probably glad they sold their shares in Clovis Oncology, Inc. (NASDAQ:CLVS) after 19% drop
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
Ask an Expert
You must be logged in to post a comment.